Transplantation of TAT-Bcl-xL-transduced neural precursor cells: long-term neuroprotection after stroke

Neurobiol Dis. 2010 Oct;40(1):265-76. doi: 10.1016/j.nbd.2010.05.033. Epub 2010 Jun 8.

Abstract

Neural precursor cells (NPC) are an interesting tool in experimental stroke research, but their therapeutic potential is limited due to poor long-term survival. We therefore in vitro transduced subventricular zone-(SVZ)-derived NPC with the anti-apoptotic fusion protein TAT-Bcl-x(L) and analyzed NPC survival, differentiation, and post-stroke functional deficits after experimental ischemia in mice. Survival of TAT-Bcl-x(L)-transduced NPC, which were injected at day 7 post-stroke into the ischemic striatum, was significantly increased at 4 weeks after stroke. Increased survival of NPC was associated with reduced infarct injury and decreased post-stroke functional deficits. Animals grafted with TAT-Bcl-x(L)-transduced NPC showed an increased number of immature cells expressing the neuronal marker doublecortin. Since mature neuronal differentiation of NPC was not observed, reduced post-stroke injury cannot be attributed to enhanced neuronal regeneration, but rather to indirect by-stander effects of grafted NPC. In line with this, NPC-mediated neuroprotection of cortical neurons in vitro was associated with increased secretion of growth factors. Thus, in vitro transduction of cultivated NPC with TAT-Bcl-x(L) results in enhanced resistance of transplanted NPC followed by long-term neuroprotection and ameliorated functional deficits after transient focal cerebral ischemia in mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / genetics*
  • Brain Ischemia / metabolism
  • Brain Ischemia / pathology
  • Brain Ischemia / surgery
  • Brain Ischemia / therapy*
  • Cell Survival / genetics
  • Cytoprotection / genetics
  • Disease Models, Animal
  • Gene Transfer Techniques
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neural Stem Cells / metabolism
  • Neural Stem Cells / pathology
  • Neural Stem Cells / transplantation*
  • Recovery of Function / genetics
  • Stem Cell Transplantation / methods*
  • Stroke / genetics
  • Stroke / pathology
  • Stroke / therapy*
  • Time
  • Transduction, Genetic / methods*
  • bcl-X Protein / genetics*
  • bcl-X Protein / therapeutic use
  • tat Gene Products, Human Immunodeficiency Virus / genetics*
  • tat Gene Products, Human Immunodeficiency Virus / therapeutic use

Substances

  • BCL2L1 protein, human
  • bcl-X Protein
  • tat Gene Products, Human Immunodeficiency Virus